Cargando…

Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Atrial fibrillation catheter ablation (AFCA) improves sinus node function and may defer a permanent pacemaker (PPM) implantation. We explored the clinical and genetic characteristics of the patients with AF and sinus node dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, J W, Hong, M H, Kim, D H, Yu, H T, Kim, T H, Uhm, J S, Joung, B Y, Lee, M H, Hwang, C, Pak, H N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207040/
http://dx.doi.org/10.1093/europace/euad122.599
_version_ 1785046361040748544
author Park, J W
Hong, M H
Kim, D H
Yu, H T
Kim, T H
Uhm, J S
Joung, B Y
Lee, M H
Hwang, C
Pak, H N
author_facet Park, J W
Hong, M H
Kim, D H
Yu, H T
Kim, T H
Uhm, J S
Joung, B Y
Lee, M H
Hwang, C
Pak, H N
author_sort Park, J W
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Atrial fibrillation catheter ablation (AFCA) improves sinus node function and may defer a permanent pacemaker (PPM) implantation. We explored the clinical and genetic characteristics of the patients with AF and sinus node dysfunction (SND) who eventually needed PPM implantation after AFCA. METHODS: Among 2,732 AF patients with genome-wide association study (GWAS, PMRA, Thermofisher scientific, MA, USA) data who underwent the first AFCA, 244 patients (65.0, IQR [59.0, 72.0] years, male 58.2%, paroxysmal AF 79.5%) had underlying SND before AFCA (class I indication for PPM). We retrospectively investigated clinical factors, single-nucleotide polymorphisms (SNPs), and their polygenic risk score (PRS) associated with PPM-AFCA. We defined the cut-off of PRS using the Youden index. RESULTS: During median 37.9 (IQR 20.3-77.9) months follow-up, 36 out of 244 patients (16.1%) with underlying SND eventually underwent PPM implantation after AFCA (PPM-AFCA). PPM-AFCA group a had a higher body mass index (p=0.013) and large left atrial (LA) dimension (p=0.006) than their counterpart. Among 44 SNPs related to AF and SND, the rs3922844 (p=0.003) near SCN5A and rs9320841 (p=0.011) and rs1015451 (p=0.046) near CJA1 were significantly associated with PPM-AFCA. The rate of PPM-AFCA implantation was significantly higher in the high PRS group (≥1.175, 25.6%) compared to the low PRS group (<1.175, 9.38%, p=0.002, Log-rank p=0.002). LA dimension (adjusted HR 1.06, 95% CI [1.00-1.13], p=0.044) and PRS (adjusted HR 2.69, 95% CI [1.68-4.31], p<0.001) were associated with a higher risk for PPM-AFCA after adjusting clinical factors including age, sex, AF type, beta blocker, and antiarrhythmic drugs after AFCA. CONCLUSIONS: In AF patients with SND, 16% with the genetic background of SCN5A and CJA1 or large atrium eventually needed PPM implantation after AFCA. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207040
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102070402023-05-25 Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation Park, J W Hong, M H Kim, D H Yu, H T Kim, T H Uhm, J S Joung, B Y Lee, M H Hwang, C Pak, H N Europace 9.1.2 - Genetic Aspects of Arrhythmias FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Atrial fibrillation catheter ablation (AFCA) improves sinus node function and may defer a permanent pacemaker (PPM) implantation. We explored the clinical and genetic characteristics of the patients with AF and sinus node dysfunction (SND) who eventually needed PPM implantation after AFCA. METHODS: Among 2,732 AF patients with genome-wide association study (GWAS, PMRA, Thermofisher scientific, MA, USA) data who underwent the first AFCA, 244 patients (65.0, IQR [59.0, 72.0] years, male 58.2%, paroxysmal AF 79.5%) had underlying SND before AFCA (class I indication for PPM). We retrospectively investigated clinical factors, single-nucleotide polymorphisms (SNPs), and their polygenic risk score (PRS) associated with PPM-AFCA. We defined the cut-off of PRS using the Youden index. RESULTS: During median 37.9 (IQR 20.3-77.9) months follow-up, 36 out of 244 patients (16.1%) with underlying SND eventually underwent PPM implantation after AFCA (PPM-AFCA). PPM-AFCA group a had a higher body mass index (p=0.013) and large left atrial (LA) dimension (p=0.006) than their counterpart. Among 44 SNPs related to AF and SND, the rs3922844 (p=0.003) near SCN5A and rs9320841 (p=0.011) and rs1015451 (p=0.046) near CJA1 were significantly associated with PPM-AFCA. The rate of PPM-AFCA implantation was significantly higher in the high PRS group (≥1.175, 25.6%) compared to the low PRS group (<1.175, 9.38%, p=0.002, Log-rank p=0.002). LA dimension (adjusted HR 1.06, 95% CI [1.00-1.13], p=0.044) and PRS (adjusted HR 2.69, 95% CI [1.68-4.31], p<0.001) were associated with a higher risk for PPM-AFCA after adjusting clinical factors including age, sex, AF type, beta blocker, and antiarrhythmic drugs after AFCA. CONCLUSIONS: In AF patients with SND, 16% with the genetic background of SCN5A and CJA1 or large atrium eventually needed PPM implantation after AFCA. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207040/ http://dx.doi.org/10.1093/europace/euad122.599 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 9.1.2 - Genetic Aspects of Arrhythmias
Park, J W
Hong, M H
Kim, D H
Yu, H T
Kim, T H
Uhm, J S
Joung, B Y
Lee, M H
Hwang, C
Pak, H N
Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
title Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
title_full Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
title_fullStr Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
title_full_unstemmed Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
title_short Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
title_sort genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
topic 9.1.2 - Genetic Aspects of Arrhythmias
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207040/
http://dx.doi.org/10.1093/europace/euad122.599
work_keys_str_mv AT parkjw geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT hongmh geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT kimdh geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT yuht geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT kimth geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT uhmjs geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT joungby geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT leemh geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT hwangc geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation
AT pakhn geneticbackgroundofsinusnodedysfunctionrequiringpermanentpacemakerimplantationafteratrialfibrillationcatheterablation